A recent U.S. federal court ruling in Thomson Reuters Enterprise Centre GmbH v. Ross Intelligence Inc. determined that ...

AI regulations are tightening, bringing new compliance challenges, especially for high-risk systems. Morrison Foerster ...

FDA proposes draft guidelines on AI use in drug development, addressing challenges and opportunities for improving safety and ...

“Too accurate AI could imminently create substantial particularized harms to individuals as well as widely dispersed costs to society,” argues Faculty Associate Aileen Nielsen. On the flip side, ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) models in ...

The medical use of artificial intelligence (AI) threatens to undermine patients' ability to make personalized decisions. New ...

The key clinical benefits of this AI-based system include more accurate newborn resuscitation timelines, ensuring ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform. This latest release introduces advanced ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, recently announced it has completed its acquisition of Ambry Genetics, a ...

Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, ...

All eyes were on French President Emmanuel Macron Sunday at the end of the first day of the Artificial Intelligence Action ...